Douglas Carr
CIK: 0001867173
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Century Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Sep 14, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $1.93$3K - Sep 8, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct254 shares at avg. $2.05$520.7 - Aug 3, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct275 shares at avg. $1.98$543.675 - Jun 12, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $2.23$4K - Jun 8, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct249 shares at avg. $2.11$525.639 - May 4, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct264 shares at avg. $2.34$618.024 - Mar 12, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct7K shares at avg. $2.55$18K - Mar 9, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct247 shares at avg. $2.54$626.392 - Feb 3, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct323 shares at avg. $1.82$588.506 - Feb 2, 2026IPSC
Century Therapeutics, Inc.
Award(A)Direct110K shares- - Dec 8, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct257 shares at avg. $0.53$136.724 - Nov 3, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct292 shares at avg. $0.59$171.112 - Sep 8, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct263 shares at avg. $0.50$131.5 - Aug 4, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct296 shares at avg. $0.53$158.064 - Jun 9, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct4.9K shares at avg. $0.62$3K - May 5, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct295 shares at avg. $0.55$162.25 - Mar 11, 2025IPSC
Century Therapeutics, Inc.
Award(A)Direct95.6K shares- - Mar 10, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct1.2K shares at avg. $0.61$762.6 - Feb 3, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct351 shares at avg. $0.78$273.78 - Nov 4, 2024IPSC
Century Therapeutics, Inc.
Sale(S)Direct283 shares at avg. $1.23$347.241 - Nov 1, 2024IPSC
Century Therapeutics, Inc.
Tax Payment(F)Direct16.6K shares at avg. $1.26$21K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 1,658 | $1.93 | $3,200 | Direct |
| Sep 8, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 254 | $2.05 | $521 | Direct |
| Aug 3, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 275 | $1.98 | $544 | Direct |
| Jun 12, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 1,654 | $2.23 | $3,692 | Direct |
| Jun 8, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 249 | $2.11 | $526 | Direct |
| May 4, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 264 | $2.34 | $618 | Direct |
| Mar 12, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 7,043 | $2.55 | $17,953 | Direct |
| Mar 9, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 247 | $2.54 | $626 | Direct |
| Feb 3, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 323 | $1.82 | $589 | Direct |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc. | Award(A) | 110,000 | - | $0 | Direct |
| Dec 8, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 257 | $0.53 | $137 | Direct |
| Nov 3, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 292 | $0.59 | $171 | Direct |
| Sep 8, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 263 | $0.50 | $132 | Direct |
| Aug 4, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 296 | $0.53 | $158 | Direct |
| Jun 9, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 4,904 | $0.62 | $3,050 | Direct |
| May 5, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 295 | $0.55 | $162 | Direct |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | Award(A) | 95,625 | - | - | Direct |
| Mar 10, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 1,240 | $0.61 | $763 | Direct |
| Feb 3, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 351 | $0.78 | $274 | Direct |
| Nov 4, 2024 | IPSC Century Therapeutics, Inc. | Sale(S) | 283 | $1.23 | $347 | Direct |
| Nov 1, 2024 | IPSC Century Therapeutics, Inc. | Tax Payment(F) | 16,611 | $1.26 | $20,930 | Direct |
1-21 of 21 transactions
About Carr Douglas
Carr Douglas (SEC CIK 0001867173) files insider reports with the SEC as SVP Finance & Operations of Century Therapeutics, Inc. (IPSC).
Signal8 holds 19 ownership filings by Carr Douglas, all Form 4s, filed between Nov 5, 2024 and Sep 15, 2026. Those filings report 21 transactions, from Nov 1, 2024 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Carr Douglas's filings is in PHILADELPHIA, PA.
Recent filings by Carr Douglas
- Sep 14, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Aug 3, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Jun 12, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Jun 8, 2026: Open-market sale of IPSC shares (Form 4, code S).
Other insiders filing for Century Therapeutics, Inc. (IPSC)
- Russotti Gregory
- Pfeiffenberger Brent, President and CEO
- Truitt Joseph, Director
- Cowan Chad, Chief Scientific Officer
- Riva Alessandro, Director
- Quimi Daphne, Director